Stock Earnings

Question 1

What are Immunocore Holdings PLC's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Immunocore Holdings PLC has a total asset of $1,010, Net loss of $-51

Question 2

What are the key financial ratios for IMCR?

Accepted Answer

Immunocore Holdings PLC's Current ratio is 1.55, has a Net margin is -16.45, sales per share of $6.2.

Question 3

How is Immunocore Holdings PLC's revenue broken down by segment or geography?

Accepted Answer

Immunocore Holdings PLC largest revenue segment is Immunotherapies, at a revenue of 310,202,000 in the most earnings release.For geography, United States is the primary market for Immunocore Holdings PLC, at a revenue of 226,900,000.

Question 4

Is Immunocore Holdings PLC profitable?

Accepted Answer

no, according to the latest financial statements, Immunocore Holdings PLC has a net loss of $-51

Question 5

Does Immunocore Holdings PLC have any liabilities?

Accepted Answer

yes, Immunocore Holdings PLC has liability of 649

Question 6

How many outstanding shares for Immunocore Holdings PLC?

Accepted Answer

Immunocore Holdings PLC has a total outstanding shares of 50

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	356	310	249	143	26	30
Revenue Growth (YoY)	-23%	25%	74%	450%	-13%	20%
Cost of Revenue	2	2	1	0	--	--
Gross Profit	353	307	248	143	--	--
Selling, General & Admin	160	155	144	90	74	45
Research & Development	239	222	163	89	73	74
Operating Expenses	399	377	308	184	154	120
Other Non Operating Income (Expenses)	20	14	0	-5	-4	0
Pretax Income	-22	-52	-60	-44	-140	-87
Income Tax Expense	-2	-1	-5	-2	-9	-13
Net Income	-20	-51	-55	-41	-131	-74
Net Income Growth	-77%	-7%	34%	-69%	77%	-28%
Shares Outstanding (Diluted)	50.29	49.99	48.88	45.7	42.5	42.3
Shares Change (YoY)	1%	2%	7%	8%	0%	0%
EPS (Diluted)	-0.41	-1.02	-1.13	-0.9	-3.1	-1.75
EPS Growth	-76%	-10%	26%	-71%	77%	-28.99%
Free Cash Flow	28	20	-2	-28	-97	-64
Free Cash Flow Per Share	0.55	0.4	-0.04	-0.61	-2.28	-1.51
Gross Margin	99.15%	99.03%	99.59%	100%	--	--
Operating Margin	-12.92%	-22.58%	-23.69%	-28.67%	-492.3%	-296.66%
Profit Margin	-5.61%	-16.45%	-22.08%	-28.67%	-503.84%	-246.66%
Free Cash Flow Margin	7.86%	6.45%	-0.8%	-19.58%	-373.07%	-213.33%
EBITDA	-43	-66	-55	-35	-121	-81
EBITDA Margin	-12.07%	-21.29%	-22.08%	-24.47%	-465.38%	-270%
D&A For EBITDA	3	4	4	6	7	8
EBIT	-46	-70	-59	-41	-128	-89
EBIT Margin	-12.92%	-22.58%	-23.69%	-28.67%	-492.3%	-296.66%
Effective Tax Rate	9.09%	1.92%	8.33%	4.54%	6.42%	14.94%

Immunocore Holdings PLC (IMCR) Price

IMCR Stock Price Chart

IMCR Income

Follow-Up Questions